1. Acknowledgement to Referees

   Acknowledgement to Referees 13 November 2013 Pages: 559 - 560

2. An Overview of the Health Economic Implications of Elective Caesarean Section

   • Stavros Petrou
   • Kamran Khan

   Review Article 24 October 2013 Pages: 561 - 576

3. The Economic Burden of Complications Occurring in Major Surgical Procedures: a Systematic Review

   • Ajay S. Patel
   • Annika Bergman
   • Ulf Haglund

   Systematic Review 29 October 2013 Pages: 577 - 592

   

4. Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review

   • Ronald C. Wielage
   • Julie A. Myers
   • Michael Happich

   Systematic Review 09 November 2013 Pages: 593 - 618

   

5. Are the True Impacts of Adverse Events Considered in Economic Models of Antineoplastic Drugs? A Systematic Review

   • Alison Pearce
   • Marion Haas
   • Rosalie Viney

   Systematic Review 16 October 2013 Pages: 619 - 637

   

6. Preferences on Policy Options for Ensuring the Financial Sustainability of Health Care Services in the Future: Results of a Stakeholder Survey

   • David Tordrup
   • Aris Angelis
   • Panos Kanavos

   Original Research Article 16 October 2013 Pages: 639 - 652

   

7. Incremental Cost Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agent Clinics for Non-Dialysis-Dependent Chronic Kidney Disease Patients

   • Sherrie L. Aspinall
   • Kenneth J. Smith
   • Francesca E. Cunningham

   Original Research Article 05 October 2013 Pages: 653 - 660

   

8. A Model-Based Economic Evaluation of Improved Primary Care Management of Patients with Type 2 Diabetes in Australia

   • Hossein Haji Ali Afzali
   • Jodi Gray
   • Jonathan Karnon

   Original Research Article 16 November 2013 Pages: 661 - 670

   

9. Direct Medical Cost and Glycemic Control in Type 2 Diabetic Saudi Patients

   • Nora Almutairi
   • Khalid M. Alkharfy

   Original Research Article 31 October 2013 Pages: 671 - 675

   

10. Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries

    • Ulrik Hesse
    • Brian Godman
    • Rickard E. Malmström

    Short Communication 09 October 2013 Pages: 677 - 685

    

11. Erratum to: Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

    • Dawn Lee
    • Patrick Thornton
    • Nic Brereton

    Erratum 30 October 2013 Pages: 687 - 687

12. Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany

    • Jan Zeidler
    • Jörg Mahlich
    • Stephan Heres

    Erratum 24 September 2013 Pages: 689 - 689